Jitendra Tyagi — Head of US Drug Makers - India at Bristol Myers Squibb | Comparably
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals. read more
EMPLOYEE
PARTICIPANTS
262
TOTAL
RATINGS
2266
Jitendra Tyagi — Head of US Drug Makers - India at Bristol Myers Squibb

Jitendra Tyagi — Head of US Drug Makers - India at Bristol Myers Squibb

Executive Bio

Mr. Jitendra Tyagi has been Head of US Drug Makers - India at Bristol-Myers Squibb Company since July 2014. Mr. Tyagi joined Bristol-Myers Squibb in 2010 and has held various positions. Most recently, he was head of the Critical Care and Cardiovascular Business Unit. Mr. Tyagi was previously with Novartis, where he spent 21 years. He was head of the Critical Care and Cardiovascular Business Unit. Mr. Tyagi was previously with Novartis, where he spent 21 years.

Executive Team Culture Ratings from Bristol Myers Squibb Employees

TOP
20%
Bristol Myers Squibb's Executive Team scores in the Top 20%
of similar sized companies on Comparably
Who ranks the Executive Team the highest?
Department - Finance 95/100
Tenure - 1 to 2 Years 78/100
Tenure - 2 to 5 Years 78/100
Who ranks the Executive Team the lowest?
Ethnicity - Asian or Pacific Islander 63/100
Experience - 1 to 3 Years 68/100
Tenure - 5 to 10 Years 68/100

Bristol Myers Squibb's Executive Team at a Glance

Based on 129 ratings, Bristol Myers Squibb's employees are satisfied with their Executive Team and give them a ā€œB+ā€ or 74/100. On average, Men provided higher ratings for their Executive Team compared to Women. Also, the Finance department thinks more highly of the Executive Team relative to the IT department.

Bristol Myers Squibb's Executive Team ranks in the Top 30% of other companies in New York and Top 20% of other companies on Comparably that also have 10,000+ Employees.

×
Rate your company